Improved pediatric clinical administration device

Abstract

The utility model discloses an improved pediatric clinical administration device which comprises an injector and a connecting sleeve, a first connecting ring is arranged at the bottom of the injector, a second connecting ring is arranged at the top of the connecting sleeve, and a sealing rubber ring is arranged at the top of the second connecting ring. A connecting assembly convenient to disassemble is arranged on the outer side of the upper portion of the second connecting ring and used for being connected with the first connecting ring, a hose is arranged below the connecting sleeve, and a dripping assembly is arranged at the bottom of the hose and used for preventing medicine from being sprayed into the mouth of a child. The administration ball is placed in the mouth of a child, the situation that the child spits medicine can be reduced, the injected medicine is conveyed into the administration ball through the hose and falls on the nanometer cushion layer, namely, the medicine can be effectively prevented from sputtering through the nanometer cushion layer, and therefore the medicine flows out of the multiple administration openings in the outer side, and the administration effect of the child is improved. The situation that the child is uncomfortable due to the fact that medicine is directly sprayed into the mouth of the child can be avoided.

Description

Technical Field

[0001] This utility model relates to the field of pediatric clinical drug delivery technology, specifically an improved pediatric clinical drug delivery device. Background Technology

[0002] Pediatrics is a comprehensive medical science that studies the physical and mental development, health care, and disease prevention of children. All health and hygiene issues involving children and adolescents fall under the scope of pediatrics. Its patients are in a period of growth and development. Clinical medication in pediatrics requires comprehensive consideration of factors such as the child's age, condition, and the nature of the medication.

[0003] Currently, when administering medication to children, syringes are typically used to inject the drugs into their mouths instead of spoons. However, during the injection process, the medication is sprayed directly into the child's mouth, which may cause discomfort and resistance. Furthermore, since the injection is always done directly into the child's mouth, if the medication is bitter, the child may spit out a large amount of the medication, making medication administration inconvenient. Utility Model Content

[0004] The purpose of this invention is to provide an improved pediatric clinical drug delivery device to solve the problems mentioned in the background art.

[0005] To achieve the above objectives, this utility model provides the following technical solution:

[0006] An improved pediatric clinical drug delivery device includes a syringe and a connecting sleeve. The syringe has a first connecting ring at its bottom, and the connecting sleeve has a second connecting ring at its top. The second connecting ring has a sealing ring at its top. A detachable connecting component is located on the outer side above the second connecting ring. The connecting component is used to connect to the first connecting ring. A flexible tube is located below the connecting sleeve, and a dripping component is located at the bottom of the flexible tube. The dripping component is used to prevent the drug from being sprayed into the child's mouth.

[0007] In a preferred embodiment of the present invention, a sealing groove is provided at the bottom of the first connecting ring, and the sealing rubber ring is attached to the sealing groove.

[0008] In a preferred embodiment of the present invention, limit bolts are provided on both sides of the bottom of the first connecting ring, and limit openings are provided on both sides of the top of the second connecting ring, wherein the limit bolts and the limit openings are slidably connected.

[0009] In a preferred embodiment of the present invention, the connecting component includes two connectors, the second connecting ring has connecting ports on both outer sides, the connector has a connecting bolt at the bottom, and the connecting bolt is movably connected to the connecting port.

[0010] In a preferred embodiment of this utility model, the first connecting ring is provided with sockets on both outer sides, and the connector is provided with a rubber plug on the inner side, and the rubber plug is installed and removed from the sockets.

[0011] In a preferred embodiment of this utility model, the bottom of the connecting sleeve is provided with an external threaded port, and the top of the hose is provided with an internal threaded port, wherein the internal threaded port and the external threaded port are threadedly connected.

[0012] In a preferred embodiment of the present invention, the dripping assembly includes a drug delivery ball, which is made of a flexible material, has a nano-pad layer disposed on the bottom inner side of the drug delivery ball, and has multiple drug delivery ports disposed on the outer side of the drug delivery ball.

[0013] Additional aspects and advantages of this invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention.

[0014] Beneficial effects: By connecting the inner and outer threads, the connecting sleeve is connected to the tubing. When injecting medication, the connecting sleeve is placed at the child's mouth position, and the medication ball extends through the tubing, placing it inside the child's mouth. This reduces the likelihood of the child spitting out the medication. The injected medication is delivered to the medication ball through the tubing and falls into the nano-pad layer, which effectively prevents medication splashing. The medication flows out from multiple external injection ports, thus avoiding direct spraying into the child's mouth and causing discomfort.

[0015] The above description is merely an overview of the technical solution of this utility model. In order to better understand the technical means of this utility model and to implement it according to the contents of the specification, the preferred embodiments of this utility model are described in detail below with reference to the accompanying drawings. The specific implementation methods of this utility model are given in detail in the following embodiments and their accompanying drawings. Attached Figure Description

[0016] The above and / or additional aspects and advantages of this utility model will become apparent and readily understood from the description of the embodiments taken in conjunction with the following drawings, in which:

[0017] Figure 1 This is a schematic diagram of the main structure of an improved pediatric clinical drug delivery device;

[0018] Figure 2 This is a schematic diagram of the syringe bottom structure in an improved pediatric clinical drug delivery device;

[0019] Figure 3 This is a schematic diagram of the connecting sleeve structure in an improved pediatric clinical drug delivery device;

[0020] Figure 4This is a schematic diagram of the tubing structure in an improved pediatric clinical drug delivery device;

[0021] Figure 5 This is a schematic diagram of the drug delivery ball structure in an improved pediatric clinical drug delivery device.

[0022] In the diagram: 1. Syringe; 11. First connecting ring; 12. Sealing groove; 13. Limiting bolt; 14. Insert; 2. Connecting sleeve; 21. Sealing ring; 22. Second connecting ring; 23. Limiting port; 24. External threaded port; 3. Connector; 31. Connecting bolt; 32. Connecting port; 33. Rubber plug; 4. Tube; 41. Drug delivery ball; 42. Internal threaded port; 43. Nanoparticle pad; 44. Drug delivery port. Detailed Implementation

[0023] The embodiments of this utility model are described in detail below. Examples of these embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals denote the same or similar elements or elements having the same or similar functions throughout. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain this utility model, and should not be construed as limiting this utility model.

[0024] Please refer to Figures 1-5 This utility model discloses an improved pediatric clinical drug delivery device, comprising a syringe 1 and a connecting sleeve 2. The syringe 1 is the drug delivery device used to inject drugs into a child's mouth. The connecting sleeve 2 is a connecting structure and is made of flexible material. When injecting drugs, the connecting sleeve 2 is placed at the child's mouth. The syringe 1 has a first connecting ring 11 at its bottom and the connecting sleeve 2 has a second connecting ring 22 at its top. The first connecting ring 11 and the second connecting ring 22 are connected to each other, thereby connecting the syringe 1 and the connecting sleeve 2. The second connecting ring 22 has a sealing ring 21 at its top and the first connecting ring 11 has a sealing groove 12 at its bottom. When the first connecting ring 11 and the second connecting ring 22 are connected, the sealing ring 21 is attached to the sealing groove 12, thereby ensuring a sealing effect at the connection position.

[0025] A detachable connecting component is provided on the outer side of the upper part of the second connecting ring 22. The connecting component is used to connect the first connecting ring 11. Limiting bolts 13 are provided on both sides of the bottom of the first connecting ring 11, and limiting ports 23 are provided on both sides of the top of the second connecting ring 22. The limiting bolts 13 and the limiting ports 23 are slidably connected. The connecting component includes two connecting parts 3. The connecting parts 3 are connecting structures. Connecting ports 32 are provided on both sides of the outer part of the second connecting ring 22, and connecting bolts 31 are provided at the bottom of the connecting parts 3. The connecting bolts 31 are movably connected to the connecting ports 32, that is, the connecting bolts 31 connect to the connecting ports 32, so that the two connecting parts 3 are respectively installed on both sides of the outer part of the second connecting ring 22, and can move on the connecting ports 32 through the connecting bolts 31. This allows the connector 3 to move. The first connecting ring 11 has sockets 14 on both sides of its outer surface, and a rubber plug 33 is provided on the inner side of the connector 3. The rubber plug 33 is made of rubber and can be contracted to a certain extent, allowing it to be installed and removed from the sockets 14. When the first connecting ring 11 and the second connecting ring 22 are connected, the limiting bolt 13 aligns with the limiting port 23 to ensure accurate connection. Then, the connectors 3 on both sides move, allowing the rubber plug 33 to be inserted into the sockets 14, thus fixing the connection between the first connecting ring 11 and the second connecting ring 22. Conversely, disassembly and assembly are also possible. This makes disassembly and assembly convenient, allowing for quick assembly and administration of the drug after the syringe 1 has absorbed the medication.

[0026] A flexible tube 4 is installed below the connecting sleeve 2. The flexible tube 4 is a connecting structure. The bottom of the connecting sleeve 2 has an external thread 24, and the top of the flexible tube 4 has an internal thread 42. The internal thread 42 and the external thread 24 are threaded together, that is, the internal thread 42 connects to the external thread 24, thereby connecting the connecting sleeve 2 to the flexible tube 4. Conversely, they can be disassembled for easy cleaning. The connecting sleeve 2 and the flexible tube 4 are connected. A drip assembly is installed at the bottom of the flexible tube 4 to prevent the medicine from being sprayed into the child's mouth. The drip assembly includes a drug delivery ball 41, which is made of flexible material and is connected to the flexible tube 4. The drug delivery ball 41 is hollow. The drug delivery ball 41 has a nano-pad 43 at its inner bottom, which is made of nanomaterials. The drug delivery ball 41 has multiple delivery ports 44 on its outer side. The injected drug is delivered to the drug delivery ball 41 through the tubing 4 and falls into the nano-pad 43. The nano-pad 43 effectively prevents drug splashing, allowing the drug to flow out from the multiple delivery ports 44 on the outside. This avoids the drug being sprayed directly into the child's mouth, which could cause discomfort. Furthermore, when administering the drug, the drug delivery ball 41 is extended through the tubing 4 and placed inside the child's mouth, which can reduce the likelihood of the child spitting out the drug.

[0027] The working principle of this utility model is as follows: The drug is absorbed by the syringe 1, and the limiting plug 13 is connected to the limiting port 23 to ensure accurate connection. Then, the connecting parts 3 on both sides are moved to insert the rubber plug 33 into the socket 14, which fixes the connection between the first connecting ring 11 and the second connecting ring 22. The sealing ring 21 is attached to the sealing groove 12 to ensure the sealing effect of the connection position. The inner thread 42 is connected to the outer thread 24, so that the connecting sleeve 2 is connected to the tubing 4. When injecting the drug, the connecting sleeve 2 is placed at the child's mouth position, and the drug delivery ball 41 is extended through the tubing 4 to place the drug delivery ball 41 inside the child's mouth, which can reduce the child spitting out the drug. The injected drug is delivered to the drug delivery ball 41 through the tubing 4 and falls into the nano-pad 43. The nano-pad 43 can effectively prevent drug splashing, so that the drug flows out from the multiple drug delivery ports 44 on the outside, thus avoiding the drug being sprayed directly into the child's mouth and causing discomfort to the child.

[0028] Although embodiments of the present invention have been shown and described, those skilled in the art will understand that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the present invention, the scope of which is defined by the claims and their equivalents.

Claims

1. An improved paediatric clinical administration device comprising a syringe (1), a connecting sleeve (2), characterised in that: The syringe (1) is provided with a first connecting ring (11) at the bottom, the connecting sleeve (2) is provided with a second connecting ring (22) at the top, the second connecting ring (22) is provided with a sealing ring (21) at the top, and a connecting component that is easy to disassemble is provided on the outer side above the second connecting ring (22). The connecting component is used to connect the first connecting ring (11). A soft tube (4) is provided below the connecting sleeve (2), and a dripping component is provided at the bottom of the soft tube (4). The dripping component is used to prevent the drug from being sprayed into the child's mouth. The dripping component includes a drug delivery ball (41). The drug delivery ball (41) is made of flexible material. A nano-pad layer (43) is provided on the bottom inner side of the drug delivery ball (41). Multiple drug delivery ports (44) are provided on the outer side of the drug delivery ball (41).

2. The improved clinical administration device for pediatric use as claimed in claim 1, wherein, The bottom of the first connecting ring (11) is provided with a sealing groove (12), and the sealing ring (21) is attached to the sealing groove (12).

3. The improved clinical administration device for pediatric use as claimed in claim 1 wherein, The first connecting ring (11) has limit bolts (13) on both sides of its bottom, and the second connecting ring (22) has limit ports (23) on both sides of its top. The limit bolts (13) and the limit ports (23) are slidably connected.

4. The improved clinical administration set for pediatric use as claimed in claim 1 wherein, The connecting assembly includes two connectors (3), and the second connecting ring (22) has connecting ports (32) on both sides of its outer side. The connector (3) has a connecting bolt (31) at its bottom, and the connecting bolt (31) is movably connected to the connecting port (32).

5. The improved clinical administration set for pediatric use as claimed in claim 4 wherein, The first connecting ring (11) has sockets (14) on both sides of its outer side, and the connector (3) has a rubber plug (33) on its inner side. The rubber plug (33) is installed and removed from the socket (14).

6. The improved clinical administration set for pediatric use as claimed in claim 1 wherein, The bottom of the connecting sleeve (2) is provided with an external thread (24), and the top of the hose (4) is provided with an internal thread (42). The internal thread (42) and the external thread (24) are connected by threads.

Images